The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Rheumatology Research Foundation Funds 5 COVID-19 Studies for $1.65 Million

Rheumatology Research Foundation Funds 5 COVID-19 Studies for $1.65 Million

May 13, 2021 • By Kimberly Retzlaff

  • Tweet
  • Email
Print-Friendly Version / Save PDF
AnotherPerfectDay / shutterstock.com

AnotherPerfectDay / shutterstock.com

In spring 2020, as it became obvious that COVID-19 wasn’t going anywhere anytime soon, the leaders of the Rheumatology Research Foundation implemented an expedited process to distribute research funding beyond its typical awards program. This resulted in the Foundation awarding $1.65 million to fund five research studies that will look at the relationships between rheumatic diseases and SARS-CoV-2, the virus that causes COVID-19, as well as the pandemic’s effect on healthcare delivery.

You Might Also Like
  • Rheumatology Research Foundation Funds Study In Juvenile Arthritis
  • Rheumatology Research Foundation Funds Advance Investigator’s Career
  • Rheumatology Research Foundation Grant Funds Training to Improve Patient Care
Explore This Issue
May 2021
Also By This Author
  • One-Year Transition Period May Ease the Pain of ICD-10

“This was a great team effort among Foundation leadership, staff and stakeholders,” says Foundation President S. Louis Bridges Jr., MD, PhD. “When we saw the need for funding to address COVID-19 in patients with rheumatologic conditions, we quickly identified areas of research focus that would be most impactful.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The five projects chosen for funding will investigate various facets of the intersection between COVID-19 and rheumatology, including the use of telehealth, patient outcomes and health-related quality of life after COVID-19 infection, and the link between outcomes and immune response. The intention is to ultimately improve care for patients with rheumatic disease who are affected by COVID-19.

Telehealth

Two grants were awarded to study telehealth in rheumatology, including how it is used, how it affects patient care and what it might be used for in the future.

Maria Danila, MD, MSc, MSPH

Dr. Danila

Maria Danila, MD, MSc, MSPH, of the University of Alabama at Birmingham, will conduct a multi-site, randomized, noninferiority, controlled clinical trial to compare telehealth with in-office rheumatology related to patient satisfaction and patient preference. Dr. Danila received an Innovative Research Award for her study, Effectiveness of Telerheumatology for Delivering High-Quality Rheumatology Care During the COVID-19 Crisis.

The idea for this research, she says, resulted from the exponential increase in the use of telehealth during the pandemic and the questions this raised regarding its efficacy and satisfaction. Another question is whether telehealth could remain an appropriate method of care after the pandemic.

“We hope that our findings will be useful in shaping rheumatology practice in the future and that patients, clinicians and policymakers will be able to use the results to inform their decisions about telerheumatology practice,” Dr. Danila says.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Swamy Venuturupalli, MD, FACR, has similar hopes for his study, Telehealth-delivered HealthcaRe to ImproVE Care (THRIVE) in Community-Practice Rheumatology, for which he received the Norman B. Gaylis, MD, Clinical Research Award.

Bridges

Dr. Bridges

As a community rheumatologist at Attune Health, Beverly Hills, Calif., Dr. Venuturupalli had to adjust quickly to COVID-19 to keep his patients, staff and himself safe. Not only did this require changing how he was seeing patients—on screen instead of face to face—but it changed the questions he needed to ask and how he conducted examinations. This led Dr. Venuturupalli to wonder whether telehealth is effective for patients, whether it could create a way to improve patient care and, assuming telehealth is still a thing post-pandemic, what it might look like in the future.

To answer these questions, Dr. Venuturupalli and his team, which includes experts in outcomes measures and patient communication, have two aims in mind. First, the team wants to create a practical guidance document for patients and physicians that outlines best practices for telehealth, which they’ll do based on the results of a systematic literature review. Then, the team intends to demonstrate how telehealth compares to in-person medicine for measuring disease state and achieving positive patient outcomes. This will involve a patient study.

Pages: 1 2 3 4 | Single Page

Filed Under: From the College Tagged With: COVID-19, Grants, Rheumatology Research FoundationIssue: May 2021

You Might Also Like:
  • Rheumatology Research Foundation Funds Study In Juvenile Arthritis
  • Rheumatology Research Foundation Funds Advance Investigator’s Career
  • Rheumatology Research Foundation Grant Funds Training to Improve Patient Care
  • Rheumatology Research Foundation Reaches $60 Million Journey to Cure Goal

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)